 |
|
Certain type of colitis now more common, severe among hospitalized patients
July 17, 2007The rate of cases of colitis (colon inflammation) caused by the bacteria Clostridium difficile more than doubled among patients hospitalized in the United States between 1993 and 2003, and the illness was more severe and associated with an increased mortality rate, according to a report in the July issue of Archives of Surgery, one of the JAMA/Archives journals.
C. difficile inhabits the intestines of approximately 1 percent to 3 percent of healthy adults and about 20 percent of patients receiving antibiotics, according to background information in the article. When the balance of bacteria in the colon is altered, C. difficile can cause a variety of symptoms, including severe or complicated diarrhea that may eventually lead to death. Treatment for life-threatening forms of the disease usually involves colectomy, or removal of all or part of the colon, which is associated with a high rate of complications and high mortality. "Three million new cases of C. difficile colitis occur in the United States each year: as many as 10 percent of patients hospitalized for at least two days are affected," the authors write. "Anecdotal evidence and some case series suggest that C. difficile colitis has become more common and potentially more pathogenic."
Rocco Ricciardi, M.D., M.P.H., then of the University of Minnesota Medical School, Minneapolis, and now of Lahey Clinic, Burlington. Mass., and colleagues analyzed discharge data from a database of U.S. hospitals between 1993 and 2003. The database, the Nationwide Inpatient Sample, "includes data from about 7 million hospital stays per year in 1,000 hospitals located in 35 states; thus, it approximates a 20 percent stratified sample of U.S. community hospitals," the authors write. "It provides information on patient demographics, socioeconomic factors, admission profiles, hospital profiles, state codes, discharge diagnoses, procedure codes, total charges and vital status at hospital discharge."
In the 78,091,119 discharges that occurred in the 11-year study period, 299,453 patients had a diagnosis of C. difficile colitis, a rate of 383 cases per 100,000 discharged patients. "The rate of C. difficile colitis discharges increased from 261 cases per 100,000 discharged patients in 1993 to 546 cases per 100,000 discharged patients in 2003, a 109 percent increase," the authors write. Colectomy rate, which was 2.7 per 1,000 patients overall, increased from 1.2 per 1,000 patients in 1993 to 3.4 per 1,000 patients in 2003. The total rate of death among patients with C. difficile colitis was 33.6 deaths per 100,000 discharged patients throughout the study; this rate increased 147 percent in 11 years, from 20.3 deaths per 100,000 discharged patients in 1993 to 50.2 deaths per 100,000 discharged patients in 2003.
"Hospital discharge with a C. difficile diagnosis was significantly more likely with increasing calendar year," the authors continue. "In addition, the likelihood of death and of treatment with colectomy also significantly increased over time."
The results document the changing nature of C. difficile colitis but do not offer explanations for the change, the authors note. The shift could be caused by new strains of the bacteria, its increasing resistance to antibiotics or the increasing severity of illness and therefore susceptibility to infection among hospitalized patients in the United States.
"Heightened awareness of the increasing disease burden of C. difficile colitis is an important first step in controlling the public health ramifications of this important and morbid nosocomial [hospital-acquired] infection," they conclude. (Arch Surg. 2007;142(7):624-631. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This study was supported by the University of Minnesota Academic Health Center's Clinical Scholars Research Grant. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
The rate of cases of colitis (colon inflammation) caused by the bacteria Clostridium difficile more than doubled among patients hospitalized in the United States between 1993 and 2003, and the illness was more severe and associated with an increased mortality rate, according to a report in the July issue of Archives of Surgery, one of the JAMA/Archives journals.
C. difficile inhabits the intestines of approximately 1 percent to 3 percent of healthy adults and about 20 percent of patients receiving antibiotics, according to background information in the article. When the balance of bacteria in the colon is altered, C. difficile can cause a variety of symptoms, including severe or complicated diarrhea that may eventually lead to death. Treatment for life-threatening forms of the disease usually involves colectomy, or removal of all or part of the colon, which is associated with a high rate of complications and high mortality. "Three million new cases of C. difficile colitis occur in the United States each year: as many as 10 percent of patients hospitalized for at least two days are affected," the authors write. "Anecdotal evidence and some case series suggest that C. difficile colitis has become more common and potentially more pathogenic."
Rocco Ricciardi, M.D., M.P.H., then of the University of Minnesota Medical School, Minneapolis, and now of Lahey Clinic, Burlington. Mass., and colleagues analyzed discharge data from a database of U.S. hospitals between 1993 and 2003. The database, the Nationwide Inpatient Sample, "includes data from about 7 million hospital stays per year in 1,000 hospitals located in 35 states; thus, it approximates a 20 percent stratified sample of U.S. community hospitals," the authors write. "It provides information on patient demographics, socioeconomic factors, admission profiles, hospital profiles, state codes, discharge diagnoses, procedure codes, total charges and vital status at hospital discharge."
In the 78,091,119 discharges that occurred in the 11-year study period, 299,453 patients had a diagnosis of C. difficile colitis, a rate of 383 cases per 100,000 discharged patients. "The rate of C. difficile colitis discharges increased from 261 cases per 100,000 discharged patients in 1993 to 546 cases per 100,000 discharged patients in 2003, a 109 percent increase," the authors write. Colectomy rate, which was 2.7 per 1,000 patients overall, increased from 1.2 per 1,000 patients in 1993 to 3.4 per 1,000 patients in 2003. The total rate of death among patients with C. difficile colitis was 33.6 deaths per 100,000 discharged patients throughout the study; this rate increased 147 percent in 11 years, from 20.3 deaths per 100,000 discharged patients in 1993 to 50.2 deaths per 100,000 discharged patients in 2003.
"Hospital discharge with a C. difficile diagnosis was significantly more likely with increasing calendar year," the authors continue. "In addition, the likelihood of death and of treatment with colectomy also significantly increased over time."
The results document the changing nature of C. difficile colitis but do not offer explanations for the change, the authors note. The shift could be caused by new strains of the bacteria, its increasing resistance to antibiotics or the increasing severity of illness and therefore susceptibility to infection among hospitalized patients in the United States.
"Heightened awareness of the increasing disease burden of C. difficile colitis is an important first step in controlling the public health ramifications of this important and morbid nosocomial [hospital-acquired] infection," they conclude.
JAMA and Archives Journals
In the 78,091,119 discharges that occurred in the 11-year study period, 299,453 patients had a diagnosis of C. difficile colitis, a rate of 383 cases per 100,000 discharged patients. "The rate of C. difficile colitis discharges increased from 261 cases per 100,000 discharged patients in 1993 to 546 cases per 100,000 discharged patients in 2003, a 109 percent increase," the authors write. Colectomy rate, which was 2.7 per 1,000 patients overall, increased from 1.2 per 1,000 patients in 1993 to 3.4 per 1,000 patients in 2003. The total rate of death among patients with C. difficile colitis was 33.6 deaths per 100,000 discharged patients throughout the study; this rate increased 147 percent in 11 years, from 20.3 deaths per 100,000 discharged patients in 1993 to 50.2 deaths per 100,000 discharged patients in 2003.
"Hospital discharge with a C. difficile diagnosis was significantly more likely with increasing calendar year," the authors continue. "In addition, the likelihood of death and of treatment with colectomy also significantly increased over time."
The results document the changing nature of C. difficile colitis but do not offer explanations for the change, the authors note. The shift could be caused by new strains of the bacteria, its increasing resistance to antibiotics or the increasing severity of illness and therefore susceptibility to infection among hospitalized patients in the United States.
"Heightened awareness of the increasing disease burden of C. difficile colitis is an important first step in controlling the public health ramifications of this important and morbid nosocomial [hospital-acquired] infection," they conclude. (Arch Surg. 2007;142(7):624-631. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This study was supported by the University of Minnesota Academic Health Center's Clinical Scholars Research Grant. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
The rate of cases of colitis (colon inflammation) caused by the bacteria Clostridium difficile more than doubled among patients hospitalized in the United States between 1993 and 2003, and the illness was more severe and associated with an increased mortality rate, according to a report in the July issue of Archives of Surgery, one of the JAMA/Archives journals.
C. difficile inhabits the intestines of approximately 1 percent to 3 percent of healthy adults and about 20 percent of patients receiving antibiotics, according to background information in the article. When the balance of bacteria in the colon is altered, C. difficile can cause a variety of symptoms, including severe or complicated diarrhea that may eventually lead to death. Treatment for life-threatening forms of the disease usually involves colectomy, or removal of all or part of the colon, which is associated with a high rate of complications and high mortality. "Three million new cases of C. difficile colitis occur in the United States each year: as many as 10 percent of patients hospitalized for at least two days are affected," the authors write. "Anecdotal evidence and some case series suggest that C. difficile colitis has become more common and potentially more pathogenic."
Rocco Ricciardi, M.D., M.P.H., then of the University of Minnesota Medical School, Minneapolis, and now of Lahey Clinic, Burlington. Mass., and colleagues analyzed discharge data from a database of U.S. hospitals between 1993 and 2003. The database, the Nationwide Inpatient Sample, "includes data from about 7 million hospital stays per year in 1,000 hospitals located in 35 states; thus, it approximates a 20 percent stratified sample of U.S. community hospitals," the authors write. "It provides information on patient demographics, socioeconomic factors, admission profiles, hospital profiles, state codes, discharge diagnoses, procedure codes, total charges and vital status at hospital discharge."
In the 78,091,119 discharges that occurred in the 11-year study period, 299,453 patients had a diagnosis of C. difficile colitis, a rate of 383 cases per 100,000 discharged patients. "The rate of C. difficile colitis discharges increased from 261 cases per 100,000 discharged patients in 1993 to 546 cases per 100,000 discharged patients in 2003, a 109 percent increase," the authors write. Colectomy rate, which was 2.7 per 1,000 patients overall, increased from 1.2 per 1,000 patients in 1993 to 3.4 per 1,000 patients in 2003. The total rate of death among patients with C. difficile colitis was 33.6 deaths per 100,000 discharged patients throughout the study; this rate increased 147 percent in 11 years, from 20.3 deaths per 100,000 discharged patients in 1993 to 50.2 deaths per 100,000 discharged patients in 2003.
"Hospital discharge with a C. difficile diagnosis was significantly more likely with increasing calendar year," the authors continue. "In addition, the likelihood of death and of treatment with colectomy also significantly increased over time."
The results document the changing nature of C. difficile colitis but do not offer explanations for the change, the authors note. The shift could be caused by new strains of the bacteria, its increasing resistance to antibiotics or the increasing severity of illness and therefore susceptibility to infection among hospitalized patients in the United States.
"Heightened awareness of the increasing disease burden of C. difficile colitis is an important first step in controlling the public health ramifications of this important and morbid nosocomial [hospital-acquired] infection," they conclude.
JAMA and Archives Journals
Colitis Current Events and Colitis News RSSLargest gene study of childhood IBD identifies 5 new genes
In the largest, most comprehensive genetic analysis of childhood-onset inflammatory bowel disease (IBD), an international research team has identified five new gene regions, including one involved in a biological pathway that helps drive the painful inflammation of the digestive tract that characterizes the disease.
M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers
Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers.
Probiotic Found to Be Effective Treatment for Colitis In Mice
The probiotic, Bacillus polyfermenticus, can help mice recover from colitis, a new study has found.
The bowels of infection
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology.
Discovery of genetic defect may lead to better treatments for common gut diseases
New findings related to an uncommon genetic disorder may impact the diagnosis and treatment of inflammatory bowel disease (IBD), the most common chronic gastrointestinal illness in children and teens. Two million Americans have IBD which involves inflammation of the gastrointestinal tract.
Oxidized form of a common vitamin may bring relief for ulcerative colitis
New research published in the Journal of Leukocyte Biology finds retinoic acid may alleviate ulcerative colitis and similar irritable bowel diseases.
Making bacteria make useful proteins
By adapting a single protein on the surface of the bacterium Caulobacter crescentus, researchers at the University of British Columbia have turned it into a protein production factory, making useful proteins that can act as vaccines and drugs.
Promising new target emerges for autoimmune diseases
University of Michigan scientists say they have uncovered a fundamentally new mechanism that holds in check aggressive immune cells that can attack the body's own cells.
C. difficile spores spread superbug
New research suggests that antibiotic treatment could be asymptomatically inducing the transmission of the healthcare-acquired infection, C. difficile, contributing to the outbreaks that have recently been widely reported in hospitals and other settings.
Antibiotics take toll on beneficial microbes in gut
It's common knowledge that a protective navy of bacteria normally floats in our intestinal tracts. Antibiotics at least temporarily disturb the normal balance.
More Colitis Current Events and Colitis News Articles
 |
The New Eating Right for a Bad Gut : The Complete Nutritional Guide to Ileitis, Colitis, Crohn's Disease, and Inflammatory Bowel Disease by James Scala (Author) In this completely revised and updated edition of his classic book on treating "bad gut" diseases, Dr. James Scala presents a new dietary plan that has been proven to help inflammatory bowel disease go into remission. Scala firmly believes that nutrition is preventative medicine and food is the vehicle of its practice. His drug-free food and lifestyle program offers relief from the pain and embarrassment of living with these mysterious and chronic ills while providing reassuring step-by-step guidance on: Developing a personal-testing program Identifying "safe foods" Fitness and stress-reduction techniques Dietary and vitamin supplements The New Eating Right for a Bad Gut offers a solid program for health that is uniquely focused on an area of major concern to a... |
 |
Self Healing Colitis & Crohns by David Klein (Author) This is a new paperback edition of the world's #1 self healing guide book for IBD and IBS health recovery. It explains that IBD is caused by toxic diets and lifestyle stress, and that the body requires a clean-digesting nutritious diet, rest and extra sleep in order to self-heal. This is not a plan for managing IBD and IBS, nor is this a quick-fix gimmick. Rather, this approach removes the causes of disease and promotes lasting health for everyone without medicine by supplying our biological health needs. It is based upon the venerable Natural Hygiene Self-healing System which has led million of people to lasting health. This powerful book covers diet, lifestyle and psychology, presenting the Vegan Diet Healing Plan with correct food combining. This is the only dietary approach which... |
 |
The First Year: Crohn's Disease and Ulcerative Colitis: An Essential Guide for the Newly Diagnosed (First Year, The) by Jill Sklar (Author), M.D. Manuel Sklar (Foreword) This newly revised edition includes new research and insights to help everyone newly diagnosed with IBD come to terms with their condition and the accompanying lifestyle changes – along with other vital information about IBD. |
 |
How to Cook for Crohn's and Colitis: More Than 200 Healthy, Delicious Recipes the Whole Family Will Love by Brenda Roscher (Author) How to Cook for Crohn's and Colitis is a cookbook for anyone who suffers from inflammatory bowel disease (IBD, not to be confused with irritable bowel syndrome) or cooks for someone who has the disease. While there is no known cure for Crohn's disease or ulcerative colitis, their symptoms can be controlled in part by following the dietary guidelines of the American Dietetic Association and those outlined in Dr. Fred Saibil's Crohn's Disease and Ulcerative Colitis: Everything You Need to Know and by other experts. Brenda Roscher provides sound nutritional advice and outlines the unique dietary needs of people with IBD, showing how to incorporate this information to make healthy choices about which foods to eat. The recipes in How to Cook for Crohn's and Colitis are designed... |
 |
What to Eat with IBD: A Comprehensive Nutrition and Recipe Guide for Crohn's Disease and Ulcerative Colitis by Tracie M Dalessandro MS RD CDN (Author) From a patient who is also a dietitian... Everything you need to know about nutrition and inflammatory bowel disease including healing foods, recipes, supplements and more. At the age of nineteen, author Tracie Dalessandro was diagnosed with ulcerative colitis and eventually Crohn's disease. After years of trying to heal, Dalessandro realized the power of using diet in conjunction with traditional medicine to control her inflammatory bowel disease (IBD), rather than allowing it to control her. Nutrition became the link between feeling sick and feeling well. What to Eat with IBD: A Comprehensive Nutrition and Recipe Guide for Crohn's Disease and Ulcerative Colitis is an invaluable resource containing the latest nutrition and diet information for those suffering from IBD.... |
 |
Crohn's & Colitis-Digestive Advantage Once Daily Therapy, 96 Caplets (3 Pack) by Digestive Advantage |
 |
Self Help Way To Treat Colitis and Other IBS Conditions, Second Edition by DeLamar Gibbons (Author) A new edition of the bestselling, groundbreaking work on bowel disorders Thoroughly updated and revised, The Self-Help Way to Treat Colitis and Other IBS Conditions returns with the latest research on the diseases of the gastrointestinal tract, such as ulcerative colitis, Crohn's disease, and irritable bowel syndrome. It also includes the practical, effective, do-it-yourself treatments that have made the book a classic of natural health. |
 |
Digestive Advantage Daily Dietary Management of Crohn's & Colitis Caplets, 32-Count Boxes (Pack of 2) by Digestive Advantage For Daily Dietary Management of Crohn's & Colitis. Helps relieve Inflammatory Bowel Disease symptoms! Only one per day! 24-Hour relief. Feel the advantage! Feel amazing results. Helps Relieve: Cramps; Bloating; Diarrhea; Abdominal discomfort. Digestive Ad |
 |
Why Doesn't My Doctor Know This?: Conquering Irritable Bowel Syndrome, Inflammatory Bowel Disease, Crohn's Disease and Colitis by David Dahlman (Author) You're miserable, your quality of life has changed, your medications don't help and your doctor had the nerve to tell you that diet has nothing to do with your condition. ...but you know better! You can conquer these symptoms of Irritable Bowel Syndrome, Crohn's Disease and any form of Colitis: Gas, Bloating, Indigestion, Heartburn, Reflux, GERD, Diarrhea, Constipation, Alternating Diarrhea/Constipation, Abnormal Bowel Urgency, Abnormal Bowel Frequency, Pain, Spasms, Blood, Mucous, Hemorrhoids, Hiatal Hernia. Why Doesn't My Doctor Know This? Conquering Irritable Bowel Syndrome, Inflammatory Bowel Disease, Crohn's Disease and Colitis details the only physician designed step-by-step plan combined with dietary advice and an all natural supplement program. It will end your symptoms because it... |
 |
Healing Foods: Cooking for Celiacs, Colitis, Crohn's and IBS by Elephant Publishing (Author) A year in the making, Sandra Ramacher has released Healing Foods: Cooking for Celiacs, Colitis, Crohns and IBS, a visually stunning and intelligently written cookbook. It is specifically designed to please and inspire all those who suffer from these debilitating intestinal diseases, as well as those who already live happier lives thanks to the Specific Carbohydrate Diet (TM). This book strictly adheres to the diet prescribed by Elaine Gottschall in her revolutionary book Breaking The Vicious Cycle. The Specific Carbohydrate Diet is a strict grain-free, lactose-free, and sucrose-free dietary regimen intended for those suffering from Crohn's disease, ulcerative colitis, celiac disease, diverticulitis, inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). The SCDiet has... |
| © 2009 BrightSurf.com |